Dominik Awad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dominik Awad has a total of 233 co-authors. Here are the top co-authors by number of shared publications:
- Costas Andreas Lyssiotis
Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, USA
17 shared publications - Daniel E. Frigo
Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
14 shared publications - Marina Pasca di Magliano
Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA
14 shared publications - Filip Bednar
Department of Surgery, University of Michigan, Ann Arbor, Michigan
13 shared publications - Aaron Dendekker
University of Michigan 7 Department of Molecular and Integrative Physiology Ann Arbor, Michigan
12 shared publications - Adam H. Courtney
Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA
12 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 4. CCR1 ablation activates antitumor immunity that is independent of neutrophils
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 4. CCR1 ablation activates antitumor immunity that is independent of neutrophils
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 5. CCR1 regulates both immunosuppressive and inflammatory properties of TAMs
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 5. CCR1 regulates both immunosuppressive and inflammatory properties of TAMs
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 2. CCR1 ablation has no effect on PanIN formation in KC mice
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 2. CCR1 ablation has no effect on PanIN formation in KC mice
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 6. Single-cell RNA sequencing analysis of cancer-associated fibroblasts in PDA lacking CCR1
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 6. Single-cell RNA sequencing analysis of cancer-associated fibroblasts in PDA lacking CCR1
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 1. Single-cell RNA sequencing shows CCR1 is expressed in PD
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 1. Single-cell RNA sequencing shows CCR1 is expressed in PD
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Table S1. Antibodies used for immunostaining, flow cytometry and CyTOF
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Table S1. Antibodies used for immunostaining, flow cytometry and CyTOF
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 7. Single-cell RNA sequencing analysis of the effects of CCR1 ablation on T cells
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 7. Single-cell RNA sequencing analysis of the effects of CCR1 ablation on T cells
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 3. Compensatory mechanisms in CCR1 ablated tumor microenvironment elicits immune infiltration
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Supplemental Figure 3. Compensatory mechanisms in CCR1 ablated tumor microenvironment elicits immune infiltration
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Table S3. Single cell RNA sequencing datasets
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Table S3. Single cell RNA sequencing datasets
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Table S2. Primer sequences for quantitative RT-PCR
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer
Table S2. Primer sequences for quantitative RT-PCR